良性前列腺增生与下尿路症状的病理生理学：当前概念
Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts.
作者信息
Lee Cheng-Ling, Kuo Hann-Chorng
机构信息
Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.
出版信息
Tzu Chi Med J. 2017 Apr-Jun;29(2):79-83. doi: 10.4103/tcmj.tcmj_20_17.
Abstract
Lower urinary tract symptoms (LUTS) are highly prevalent in the aging population, particularly in men. Historically, prostate enlargement was thought to be responsible for most cases of male LUTS. Several risk factors for the development of benign prostate enlargement/hyperplasia (BPE/BPH) have been identified, including age, genetics, hormones, growth factors, inflammation, and lifestyle factors. However, as our knowledge continues to evolve, male LUTS are no longer managed entirely in a prostate-centric fashion. In this article, we review current concepts in the epidemiology, etiology, and pathophysiology of BPE/BPH and male LUTS.
摘要
下尿路症状（LUTS）在老年人群中非常普遍，尤其是在男性中。从历史上看，前列腺肿大被认为是大多数男性下尿路症状病例的病因。已经确定了良性前列腺肿大/增生（BPE/BPH）发展的几个风险因素，包括年龄、遗传、激素、生长因子、炎症和生活方式因素。然而，随着我们的认识不断发展，男性下尿路症状不再完全以前列腺为中心进行处理。在本文中，我们综述了BPE/BPH和男性下尿路症状的流行病学、病因学和病理生理学的当前概念。
相似文献
1
Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts.
Tzu Chi Med J. 2017 Apr-Jun;29(2):79-83. doi: 10.4103/tcmj.tcmj_20_17.
3
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
4
The role of prostate inflammation and fibrosis in lower urinary tract symptoms.
Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F817-F821. doi: 10.1152/ajprenal.00602.2015. Epub 2016 Jul 20.
5
Comprehensive patient evaluation for benign prostatic hyperplasia.
Urology. 1998 Apr;51(4A Suppl):13-8. doi: 10.1016/s0090-4295(98)00050-8.
6
Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia.
Rev Urol. 2004;6 Suppl 9(Suppl 9):S3-S10.
7
Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.
Tzu Chi Med J. 2017 Jan-Mar;29(1):6-11. doi: 10.4103/tcmj.tcmj_3_17.
8
[Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].
Urologie. 2023 Aug;62(8):805-817. doi: 10.1007/s00120-023-02142-0. Epub 2023 Jul 4.
9
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Eur Urol. 2016 Jul;70(1):124-133. doi: 10.1016/j.eururo.2015.12.048. Epub 2016 Jan 22.
10
Benign prostatic hyperplasia: from bench to clinic.
Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19.
引用本文的文献
1
Smooth muscle of the lower urinary tract: BK-RyR coupling in physiology and pathophysiology.
J Muscle Res Cell Motil. 2025 Sep 1. doi: 10.1007/s10974-025-09707-w.
2
A Comparative Study of Transurethral Resection of the Prostate (TURP) Versus Transurethral Incision of the Prostate (TUIP) in Small-Sized Prostate Glands With Benign Prostatic Hyperplasia.
Cureus. 2025 Jun 27;17(6):e86848. doi: 10.7759/cureus.86848. eCollection 2025 Jun.
3
Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Detrusor Underactivity or Acontractile Bladder.
Int Neurourol J. 2025 Jun;29(2):118-124. doi: 10.5213/inj.2550020.010. Epub 2025 Jun 30.
4
Incidence of benign prostatic hyperplasia in testicular cancer survivors in the Veteran's affairs health system.
World J Urol. 2025 Apr 25;43(1):249. doi: 10.1007/s00345-025-05631-3.
5
Developmental polychlorinated biphenyl (PCB) exposure impacts on voiding physiology persist into adulthood and influence sensitivity to bladder stimuli in mice.
Curr Res Toxicol. 2025 Mar 8;8:100227. doi: 10.1016/j.crtox.2025.100227. eCollection 2025.
6
Expert consensus on Rezūm™: Indications, surgical technique and postoperative care.
BJUI Compass. 2025 Feb 15;6(2):e491. doi: 10.1002/bco2.491. eCollection 2025 Feb.
7
Prostatectomy outcomes for patients with benign prostatic hyperplasia and its associated factors in East and West Gojjam zones comprehensive specialized hospitals, Northwest Ethiopia.
Eur J Med Res. 2024 Dec 26;29(1):629. doi: 10.1186/s40001-024-02249-w.
8
Imaging patterns of the arterial supply of the prostate gland in adult Ghanaian men.
Res Diagn Interv Imaging. 2023 Jan 5;5:100020. doi: 10.1016/j.redii.2022.100020. eCollection 2023 Mar.
9
The Effect of Long-Term Tamsulosin Monotherapy and Tamsulosin - Dutasteride Combination Therapy on PKC-α Enzyme Expression in Prostate Stromal Tissue.
Med Arch. 2023;77(6):446-450. doi: 10.5455/medarh.2023.77.446-450.
10
Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus.
Cent European J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47. Epub 2023 Jul 13.
本文引用的文献
1
Chromosomal aberrations in benign prostatic hyperplasia patients.
Investig Clin Urol. 2016 Jan;57(1):45-9. doi: 10.4111/icu.2016.57.1.45. Epub 2016 Jan 11.
2
Alcohol, Smoking, Physical Activity, Protein, and Lower Urinary Tract Symptoms: Prospective Longitudinal Cohort.
Int Neurourol J. 2015 Sep;19(3):197-206. doi: 10.5213/inj.2015.19.3.197. Epub 2015 Sep 22.
3
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19.
4
Cooperative effects of EGF, FGF, and TGF-β1 in prostate stromal cells are different from responses to single growth factors.
Life Sci. 2015 Feb 15;123:18-24. doi: 10.1016/j.lfs.2014.12.006. Epub 2014 Dec 18.
5
Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Am J Pathol. 2015 Feb;185(2):293-301. doi: 10.1016/j.ajpath.2014.10.012. Epub 2014 Nov 26.
6
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
BJU Int. 2015 Apr;115(4):508-19. doi: 10.1111/bju.12745. Epub 2014 Oct 16.
7
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
BJU Int. 2015 Jan;115(1):24-31. doi: 10.1111/bju.12728. Epub 2014 Aug 16.
8
Personalized medicine for the management of benign prostatic hyperplasia.
J Urol. 2014 Jul;192(1):16-23. doi: 10.1016/j.juro.2014.01.114. Epub 2014 Feb 25.
9
Lower urinary tract symptom: still too much focus on the prostate?
Curr Opin Urol. 2014 Jan;24(1):3-9. doi: 10.1097/MOU.0000000000000020.
10
Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.
Biomed Res Int. 2013;2013:107954. doi: 10.1155/2013/107954. Epub 2013 Jul 8.
Zotero 插件